Nascimento C, Saraiva M, Mattos Pereira V, de Brito D, de Aguiar F, Alves B
Braz J Vet Med. 2024; 45:e002523.
PMID: 38162818
PMC: 10756151.
DOI: 10.29374/2527-2179.bjvm002523.
Akel S, Poston L, Park J, Schoultz S, Alloush L, Zheng F
Cytotherapy. 2023; 25(11):1149-1154.
PMID: 37676217
PMC: 10916741.
DOI: 10.1016/j.jcyt.2023.08.004.
Page C, Rebeiro J
Can Oncol Nurs J. 2023; 33(2):199-206.
PMID: 37152819
PMC: 10155764.
DOI: 10.5737/23688076332199.
Page C, Rebeiro J
Can Oncol Nurs J. 2023; 33(2):207-214.
PMID: 37152814
PMC: 10155770.
DOI: 10.5737/23688076332207.
Haubitz M, von Petersdorff V, Helsen I, Brunold C, Oppliger Leibundgut E, Baerlocher G
Cancers (Basel). 2023; 15(5).
PMID: 36900376
PMC: 10000699.
DOI: 10.3390/cancers15051584.
A bioinspired and chemically defined alternative to dimethyl sulfoxide for the cryopreservation of human hematopoietic stem cells.
Gilfanova R, Callegari A, Childs A, Yang G, Luarca M, Gutierrez A
Bone Marrow Transplant. 2021; 56(11):2644-2650.
PMID: 34155359
PMC: 8563414.
DOI: 10.1038/s41409-021-01368-w.
Biomanufacturing for clinically advanced cell therapies.
Aijaz A, Li M, Smith D, Khong D, LeBlon C, Fenton O
Nat Biomed Eng. 2019; 2(6):362-376.
PMID: 31011198
PMC: 6594100.
DOI: 10.1038/s41551-018-0246-6.
Impact of Delayed Infusion Time in Umbilical Cord Blood Transplantation.
Mitchell R, Wagner J, Brunstein C, Cao Q, McKenna D, Verneris M
Biol Blood Marrow Transplant. 2017; 23(5):836-839.
PMID: 28214595
PMC: 5438205.
DOI: 10.1016/j.bbmt.2017.02.010.
Infusion of cryopreserved autologous lymphocytes using a standard peripheral i.v. catheter.
Gladstone D, Davis-Sproul J, Campian J, Lemas M, Malatyali S, Borrello I
Bone Marrow Transplant. 2014; 49(8):1119-20.
PMID: 24842526
PMC: 4373551.
DOI: 10.1038/bmt.2014.98.
Are orange lollies effective in preventing nausea and vomiting related to dimethyl sulfoxide? A multicenter randomized trial.
Gonella S, Berchialla P, Bruno B, Di Giulio P
Support Care Cancer. 2014; 22(9):2417-24.
PMID: 24700260
DOI: 10.1007/s00520-014-2227-y.
Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.
Shu Z, Heimfeld S, Gao D
Bone Marrow Transplant. 2013; 49(4):469-76.
PMID: 24076548
PMC: 4420483.
DOI: 10.1038/bmt.2013.152.
Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftment.
Khera N, Jinneman J, Storer B, Heimfeld S, OMeara M, Chauncey T
Biol Blood Marrow Transplant. 2011; 18(2):220-8.
PMID: 21703976
PMC: 3204152.
DOI: 10.1016/j.bbmt.2011.06.003.
A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions.
Barker J, Abboud M, Rice R, Hawke R, Schaible A, Heller G
Biol Blood Marrow Transplant. 2009; 15(12):1596-602.
PMID: 19896084
PMC: 3105472.
DOI: 10.1016/j.bbmt.2009.08.009.
Is stem cell chromosomes stability affected by cryopreservation conditions?.
Diaferia G, Dessi S, Deblasio P, Biunno I
Cytotechnology. 2008; 58(1):11-6.
PMID: 19002774
PMC: 2593762.
DOI: 10.1007/s10616-008-9163-y.
